美股A股
StockGist
Back
8-K2026-04-27· deepseek-chat

AGL · Agilon Health, Inc.

0001628280-26-027512

SEC filing

Summary

Agilon Health appoints Tim O'Rourke as CEO and President, effective May 7, 2026, with a compensation package including salary, bonus, and equity awards.

Key takeaways

Full analysis

Agilon Health announced the appointment of Tim O'Rourke as Chief Executive Officer and President, effective May 7, 2026. O'Rourke, a healthcare veteran with over 25 years of experience, most recently served as President of Help at Home, a leading in-home care provider. His background includes senior roles at Humana, Centene, and Ascension Complete, giving him deep expertise in Medicare Advantage and value-based care across both payor and provider settings. The appointment follows a comprehensive search led by the Board, as the company enters a new phase after a period of operational and financial transformation under Executive Chairman Ron Williams, who will continue as Chairman. O'Rourke's compensation package includes an $850,000 base salary, a target annual bonus of 100% of base salary, a $500,000 signing bonus, and equity awards consisting of 120,000 time-vesting RSUs and 200,000 performance-vesting PSUs with stock price targets of $50, $100, and $150 over a three-year period. The severance provisions are standard for an executive of this level, including 18 months of base salary and target bonus, continued medical coverage, and accelerated equity vesting under certain termination scenarios. This leadership change is significant for investors as it signals the company's focus on leveraging O'Rourke's integrated payor-provider experience to drive growth and performance in value-based care.